ACCME, ACPE, ADA/CERP contact hours: 4.0 or 0.40 CEUs

Thank you for taking the time to evaluate this continuing education activity. Your assistance in this evaluation process is invaluable in helping us assess your needs and to improve our programs. 
To assure anonymity, your name is NOT required. 

Question Title

* 1. Please select profession type:

Question Title

* 2. Law: Please rate your agreement that the following objectives were met.

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
List the Federal and New York State (NYS) requirements for prescribing controlled substances
Define the NYS Prescription Monitoring Program (PMP) and its purpose
Describe NYS 7-day rules

Question Title

* 3. Pain management: Please rate your agreement that the following objectives were met.

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
Describe the pathophysiology and general approaches for pain assessment in the ambulatory setting
Describe approaches for managing acute pain and how they differ from approaches for managing chronic pain
Outline evidence-based best practices for appropriate prescribing of opioid analgesics

Question Title

* 4. Opioid use disorder (OUD): Please rate your agreement that the following objectives were met.

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
Identify risk factors for the development of OUD
Describe screening tools and processes that may be used to identify signs of OUD
Describe strategies to mitigate the risk of iatrogenic OUD
Discuss treatment approaches based on whether the patient has chronic pain, OUD, both, or neither
Explain harm reduction strategies

Question Title

* 5. Palliative care: Please rate your agreement that the following objectives were met.

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
Outline principles of and differences between palliative care and hospice care
Describe the use of opioids in hospice and palliative care (e.g., cancer pain, dyspnea, methadone)

Question Title

* 6. Please rate program content:

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
The content was current
My knowledge of the subject was improved
The educational material was well organized

Question Title

* 7. Please rate the presentation by Karl D. Fiebelkorn, BSPharm, RPh, MBA:

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
The presenter demonstrated topic mastery
The speaker moved through the subject material at a reasonable pace

Question Title

* 8. Please rate the presentation by Romanth Waghmarae, MD, DABA, FACIP, FIPP:

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
The presenter demonstrated topic mastery
The speaker moved through the subject material at a reasonable pace

Question Title

* 9. Please rate the presentation by Arthur Weissman, MD, FASAM:

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
The presenter demonstrated topic mastery
The speaker moved through the subject material at a reasonable pace

Question Title

* 10. Please rate the presentation by Robert G. Wahler, Jr., PharmD, CPE:

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
The presenter demonstrated topic mastery
The speaker moved through the subject material at a reasonable pace

Question Title

* 11. Please rate the pre- and post-test assessment:

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
The pre- and post-test questions helped me assess my learning
The pre- and post-test questions were well administered

Question Title

* 12. Please rate the online delivery elements:

  Strongly Agree Agree Neither Agree nor Disagree Disagree Strongly Disagree
The instructions for the registration process were clear
The website was easy to navigate
The audio was of good quality
The video was of good quality

Question Title

* 13. Based on information presented in the program I will:

If you disagree or answer "No" to the following question, please give support for your answer. An explanation is imperative for the Office of Continuing Pharmacy Education to properly evaluate your feedback.

Question Title

* 14. The program was objective, scientifically based, and free of commercial bias:

Question Title

* 15. If you disagree, please be specific in your explanation:

Question Title

* 16. Which of the following course features attracted you to this program?

Comments:

Question Title

* 17. Please list any additional comments regarding this educational activity:

Question Title

* 18. Please list future topics you would like to see:

Question Title

* 19. How did you hear about this program?

Evaluation information is a requirement of CE accreditation.  Thank you for taking the time to complete this evaluation. Your comments will be used to assist us in improving the quality of future CE activities. 

T